ArticleLeukemia & lymphoma2017

Ganetespib, an HSP90 inhibitor, kills Epstein-Barr virus (EBV)-infected B and T cells and reduces the percentage of EBV-infected cells in the blood.

Amber Shatzer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.